case
influenza
like
ill
first
report
mexico
march
outbreak
subsequ
confirm
influenza
novel
swine
origin
influenza
viru
led
worldwid
pandem
affect
patient
novel
swine
origin
influenza
viru
soiv
molecular
featur
north
american
eurasian
swine
avian
human
influenza
virus
isol
month
world
health
organ
classifi
global
spread
viru
public
health
event
intern
concern
document
human
human
transmiss
viru
least
three
countri
two
region
rais
pandem
level
spread
rapidli
sinc
first
case
diagnos
mexico
subsequ
spread
viru
throughout
europ
winter
season
influenza
pandem
result
death
worldwid
countri
februari
turkey
report
first
laboratoryconfirm
case
influenza
may
becom
eighteenth
countri
european
region
second
case
may
clinic
pictur
sever
case
pandem
influenza
markedli
differ
diseas
pattern
seen
epidem
season
influenza
mani
affect
previous
healthi
young
peopl
current
predict
estim
pandem
wave
popul
develop
clinic
influenza
compar
season
influenza
patient
requir
hospit
admiss
one
five
requir
critic
care
pandem
influenza
viru
infect
first
pandem
intens
care
unit
icu
play
fundament
role
pandem
signific
number
patient
becam
critic
ill
primarili
respiratori
failur
patient
requir
intub
mechan
ventil
report
describ
futur
intens
care
unit
admiss
demograph
characterist
treatment
outcom
critic
ill
patient
laboratoryconfirm
suspect
infect
viru
admit
three
differ
critic
care
depart
winter
turkey
respons
outbreak
influenza
viru
infect
mexico
turkish
ministri
health
develop
case
report
form
patient
admit
hospit
critic
care
unit
accord
case
report
form
data
collect
retrospect
patient
influenza
relat
critic
ill
novemb
decemb
ethic
approv
provid
ethic
committe
meram
medic
faculti
selcuk
univers
konya
turkey
influenzalik
ill
ili
defin
fever
cough
headach
accompani
one
follow
sign
symptom
rhinorrhea
coryza
arthralgia
myalgia
prostrat
odynophagia
chest
pain
abdomin
pain
nasal
congest
data
report
attend
physician
review
medic
chart
radiolog
laboratori
record
follow
inform
record
demograph
data
comorbid
time
ill
onset
hospit
admiss
time
first
dose
antivir
deliveri
microbiolog
find
chest
radiolog
find
icu
admiss
intub
mechan
ventil
requir
advers
event
icu
stay
laboratori
find
icu
admiss
also
record
classifi
patient
accord
case
definit
confirm
probabl
suspect
develop
world
health
organ
center
diseas
control
prevent
confirm
case
novel
influenza
viru
infect
defin
person
ili
laboratori
confirm
novel
influenza
viru
infect
real
time
rtpcr
defin
critic
ill
patient
admit
adult
intens
care
unit
icu
requir
mechan
ventil
receiv
intraven
infus
inotrop
vasopressor
hospit
sever
ill
assess
adult
use
acut
physiolog
chronic
health
evalu
apach
ii
within
hour
icu
admiss
record
comorbid
prior
defin
major
comorbid
presenc
one
follow
chronic
medic
condit
asthma
chronic
obstruct
pulmonari
diseas
copd
congest
heart
failur
malign
neuromuscular
disord
cerebr
palsi
diabet
mellitu
coronari
arteri
diseas
heart
diseas
chemotherapi
malnutrit
immunosuppress
statu
renal
failur
nasopharyngealswab
specimen
collect
admiss
bronchialaspir
sampl
obtain
tracheal
intub
specimen
place
transport
medium
kept
temperatur
rtpcr
test
done
accord
publish
guidelin
us
center
diseas
control
prevent
cdc
season
vaccin
histori
radiograph
find
record
studi
form
specimen
bronchoalveolar
lavag
blood
cultur
sent
microbiolog
laboratori
detect
bacteri
infect
invas
noninvas
mechan
ventil
patient
bodymass
index
bmi
weight
kilogram
divid
squar
height
meter
calcul
obes
defin
bmi
patient
morbid
obes
defin
bmi
statist
analysi
descript
analysi
includ
frequenc
mean
standard
deviat
sd
mannwhitney
test
use
signific
group
accept
p
valu
signific
studi
period
novemb
decemb
critic
ill
patient
admit
three
differ
critic
care
unit
turkey
due
confirm
suspect
influenza
infect
assess
patient
diagnosi
confirm
realtim
pcr
pandem
viru
patient
diagnosi
suspect
accord
cdc
criteria
averag
age
year
femal
femal
male
mortal
rate
patient
mortal
rate
male
femal
p
clinic
characterist
patient
influenza
viru
infect
show
tabl
tabl
tabl
tabl
comparison
survivor
nonsurvivor
shown
symptom
present
includ
fever
cough
sputum
dyspnea
diarrhea
nausea
vomit
report
respect
mean
time
onset
ill
critic
care
admiss
day
rang
underli
medic
condit
exist
patient
obes
copd
common
condit
patient
signific
differ
accord
underli
medic
condit
nonsurvivor
survivor
group
total
patient
pregnant
anoth
underli
medic
condit
asthma
heart
diseas
pregnant
patient
first
trimest
second
trimest
third
trimest
postpartum
period
time
icu
admiss
patient
elev
lactat
dehydrogenas
level
ul
ul
ul
thirtythre
patient
elev
aspart
aminotransferas
ul
thirteen
patient
elev
alanin
aminotransferas
ul
sixteen
patient
increas
creatinin
kinas
level
mean
ul
rang
ul
creactiv
protein
measur
patient
mean
mgdl
eighteen
patient
elev
creatinin
level
mgdl
hospit
admiss
admiss
patient
test
leukopenia
anemia
thrombocytopenia
twelv
patient
posit
blood
bronchoalveolar
lavag
cultur
patient
receiv
oseltamivir
mean
time
onset
ill
initi
antivir
therapi
day
rang
day
patient
receiv
antivir
therapi
within
hour
onset
symptom
antivir
therapi
start
admiss
patient
admiss
patient
within
hour
admiss
patient
signific
differ
accord
time
onset
ill
initi
antivir
therapi
nonsurvivor
survivor
p
initi
time
antivir
treatment
earlier
survivor
compar
nonsurvivor
patient
receiv
antibiot
antibiot
therapi
start
admiss
patient
admiss
patient
patient
receiv
mean
two
differ
antibiot
rang
one
five
patient
receiv
one
antibiot
commonli
use
antibiot
includ
moxifloxacin
patient
linezolid
patient
ampicillinesulbactam
patient
clarithromycin
patient
piperacillintazobactam
patient
imipenem
patient
third
gener
cephalosporin
patient
vancomycin
patient
teicoplanin
patient
tigecyclin
patient
patient
data
avail
regard
use
corticosteroid
receiv
intraven
steroid
patient
receiv
corticosteroid
underli
medic
condit
common
condit
copd
asthma
chest
radiograph
find
abnorm
patient
radiograph
find
includ
bilater
infiltr
exist
patient
admiss
patient
viral
primari
pneumonia
bilater
patchi
alveolar
opac
affect
two
five
quadrant
patient
patient
mean
oxygen
satur
rang
absenc
supplementari
oxygen
supplementari
oxygen
patient
mean
oxygen
satur
rang
mean
apach
ii
score
rang
patient
ga
exchang
abnorm
admiss
ratio
rang
ard
diagnos
patient
ali
patient
clinic
evid
bacteri
infect
icu
admiss
present
patient
data
use
mechan
ventil
icu
avail
patient
noninvas
mechan
ventil
perform
patient
fifteen
patient
endotrach
intub
mean
day
fourteen
patient
initi
receiv
invas
mechan
ventil
thirti
patient
surviv
hospit
discharg
apach
ii
score
higher
nonsurvivor
survivor
p
obes
patient
nonsurvivor
group
obes
patient
surviv
group
p
day
mean
level
urea
creatinin
intern
normal
ratio
inr
heart
rate
higher
nonsurvivor
survivor
p
p
p
p
ratio
lower
nonsurvivor
survivor
third
icu
day
p
renal
failur
began
third
icu
day
renal
failur
develop
patient
die
patient
divid
two
group
accord
type
mechan
ventilatori
support
patient
mechan
ventil
first
day
icu
admiss
patient
receiv
invas
noninvas
mechan
ventil
fifteen
patient
receiv
noninvas
ventil
ultim
requir
invas
ventil
fullfac
mask
use
patient
nimv
apach
ii
score
white
blood
cell
count
neutrophil
account
higher
invas
mechan
ventil
group
nimv
group
arteri
blood
ph
lower
invas
mechan
ventil
group
nimv
group
durat
nimv
imv
day
rang
day
rang
respect
survivor
length
invas
mechan
ventil
rang
day
length
nimv
rang
day
day
signific
differ
tidal
volum
ventil
strategi
survivor
nonsurvivor
patient
surviv
like
nimv
use
time
admiss
icu
patient
die
like
imv
use
time
admiss
icu
data
critic
ill
patient
influenza
reveal
rel
younger
patient
affect
diseas
fever
respiratori
symptom
cardin
symptom
diseas
patient
rel
long
period
ill
prior
present
hospit
follow
short
period
acut
sever
respiratori
deterior
patient
sever
hypoxia
requir
high
peep
ventil
pressur
within
day
critic
ill
patient
die
previous
publish
report
highlight
case
sever
viral
pneumonia
affect
patient
younger
expect
age
patient
affect
normal
influenza
season
low
mean
age
differ
season
influenza
older
patient
appear
suscept
sever
diseas
find
consist
report
data
studi
death
occur
mostli
young
critic
ill
patient
risk
death
increas
increas
age
importantli
sever
ill
mortal
cohort
similar
demonstr
previous
novel
first
data
mexico
show
patient
previous
healthi
studi
critic
ill
patient
comorbid
differ
accord
comorbid
surviv
die
patient
histori
lung
diseas
obes
diabet
hypertens
neurolog
diseas
malign
heart
diseas
common
comorbid
studi
among
critic
ill
patient
obes
shown
risk
factor
increas
morbid
consist
mortal
studi
statist
signific
differ
due
obes
survivor
nonsurvivor
find
signific
differ
bmi
survivor
nonsurvivor
earli
metaanalysi
indic
obes
associ
increas
icu
mortal
recent
larg
cohort
studi
gong
et
al
prior
novel
infect
note
associ
obes
ard
mortal
canadian
novel
experi
likewis
suggest
bmi
differ
survivor
nonsurvivor
patient
infectionrel
critic
ill
experienc
symptom
averag
day
prior
hospit
present
rapidli
worsen
requir
care
icu
within
day
studi
durat
higher
studi
tendenc
femal
develop
sever
influenza
infect
seri
strike
gener
femal
suscept
observ
influenza
case
seri
variabl
sever
includ
report
infect
report
death
higher
male
femal
explan
increas
risk
death
among
male
report
may
due
exist
frequent
comorbid
man
infecti
diseas
relat
condit
sepsi
septic
shock
male
repres
larger
proport
case
higher
mortal
importantli
found
cohort
apach
ii
score
may
help
identifi
patient
high
risk
death
rare
use
vasopressor
support
day
follow
icu
admiss
broadspectrum
antibacteri
agent
initi
almost
chest
radiograph
demonstr
bilater
mix
interstiti
alveolar
infiltr
found
patient
studi
patient
requir
ventil
support
profound
hypoxem
respiratori
failur
requir
high
level
inspir
oxygen
peep
howev
surviv
rate
higher
nimv
invas
ventil
use
fullfac
mask
patient
nimv
noninvas
ventil
use
altern
therapi
patient
acut
respiratori
failur
hope
obviat
intub
mechan
ventil
result
nimv
hypoxem
respiratori
failur
conflict
etiolog
hypoxemia
appear
import
determin
success
ferrer
et
al
compar
nimv
convent
ventur
oxygen
deliveri
patient
sever
hypoxem
respiratori
failur
found
nimv
decreas
need
intub
benefit
observ
subgroup
patient
pneumonia
ard
intub
rate
high
group
metaanalysi
suggest
nimv
decreas
need
intub
enough
evid
support
use
ard
patient
mechan
ventil
first
day
icu
admiss
invas
noninvas
fifteen
patient
receiv
noninvas
ventil
ultim
requir
invas
ventil
dominguezcherit
et
al
report
invas
ventil
use
patient
kumar
studi
invas
ventil
use
patient
swine
flu
associ
respiratori
failur
studi
use
noninvas
ventil
critic
patient
influenza
admiss
icu
critic
ill
patient
influenza
infect
high
level
peep
often
use
achiev
adequ
oxygen
studi
patient
ard
often
peep
refractori
hypoxemia
also
note
patient
improv
wean
process
start
oxygen
sensit
small
decrement
peep
use
high
peep
level
patient
use
noninvas
mechan
ventil
signific
problem
risk
transmit
infecti
diseas
use
noninvas
ventil
identifi
risk
factor
transmit
infect
due
exposur
aerosol
sar
epidem
advis
avoid
noninvas
ventil
sar
epidem
expert
opinion
experiment
model
claim
noninvas
ventilatori
support
may
increas
occup
risk
howev
shown
multipl
time
noninvas
ventilatori
support
may
decreas
mortal
avoid
endotrach
intub
difficult
identifi
immedi
patient
infect
epidem
noninvas
ventil
initi
chose
ventilatori
support
patient
alway
potenti
harm
withhold
procedur
epidem
even
risk
use
noninvas
ventil
patient
sinc
may
save
live
decid
use
strict
isol
includ
neg
pressur
isol
room
conclus
demonstr
influenza
infectionrel
critic
ill
predominantli
affect
young
patient
littl
major
comorbid
associ
sever
hypoxem
respiratori
failur
often
requir
prolong
mechan
ventil
among
patient
admit
icu
older
age
requir
invas
ventil
associ
increas
risk
death
greater
number
younger
patient
cohort
major
death
occur
younger
patient
altern
nimv
could
use
influenza
infectionrel
hypoxem
respiratori
failur
